SuperGen, Inc. to Present at UBS Global Life Sciences Conference on September 22nd

DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that Mohammad Azab, M.D., Chief Medical Officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 22nd in New York.
MORE ON THIS TOPIC